ICD-10 Coding for Hodgkin Lymphoma(C81.0, C81.1)
Complete ICD-10-CM coding and documentation guide for Hodgkin Lymphoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Hodgkin Lymphoma
C81Primary Range
Hodgkin Lymphoma
This range includes all subtypes of Hodgkin Lymphoma, which is the primary focus for diagnosis and coding.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C81.0 | Nodular lymphocyte predominant Hodgkin lymphoma | Use when histopathology confirms nodular lymphocyte predominant subtype. |
|
| C81.1 | Nodular sclerosis Hodgkin lymphoma | Use when biopsy confirms nodular sclerosis subtype. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for Hodgkin Lymphoma
Essential facts and insights about Hodgkin Lymphoma
Primary ICD-10-CM Codes for hodgkin lymphoma
Decision Criteria
clinical Criteria
- Histopathology confirms nodular lymphocyte predominant subtype.
Applicable To
- Nodular lymphocyte predominant Hodgkin lymphoma
Excludes
- Non-Hodgkin lymphoma
Clinical Validation Requirements
- Histopathology showing Reed-Sternberg cells
- CD30 and CD15 positivity
Code-Specific Risks
- Ensure histopathology is specific to nodular lymphocyte predominant subtype.
Coding Notes
- Ensure documentation specifies subtype and histopathological findings.
C81.1 - Nodular sclerosis Hodgkin lymphoma
Use when biopsy confirms nodular sclerosis subtype.
Applicable To
- Nodular sclerosis Hodgkin lymphoma
Excludes
- Non-Hodgkin lymphoma
Clinical Validation Requirements
- Pathology report specifying collagen bands dividing lymphoid tissue
- Flow cytometry excluding NHL (CD20-)
Coding Notes
Document staging and treatment response.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Personal history of Hodgkin lymphoma
Z85.71Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Hodgkin Lymphoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C81.0.
Impact
Clinical: Misrepresents current disease status., Regulatory: Non-compliance with coding guidelines., Financial: Potential for incorrect reimbursement.
Mitigation Strategy
Verify current disease status., Use remission codes appropriately.
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding standards., Data Quality: Inaccurate clinical data representation.
Mitigation Strategy
Ensure FNA cytology is coded only if a core biopsy is performed.
Impact
Incorrect use of remission codes.
Mitigation Strategy
Ensure documentation supports remission status.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Hodgkin Lymphoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Hodgkin Lymphoma
Use these documentation templates to ensure complete and accurate documentation for Hodgkin Lymphoma. These templates include all required elements for proper coding and billing.
Patient in remission
Specialty: OncologyRequired Elements
- Biopsy details
- Markers
- Staging
- Treatment response
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Hodgkin Lymphoma? Ask your questions below.